Gourt > Health > Pharmacy > Drugs and Medications > B > Bevacizumab
Bevacizumab (Avastin®) is an anti-angiogenesis drug used in treatment of cancer.
It is used in combination with standard chemotherapy drugs in patients with metastatic colorectal cancer. The U.S. Food and Drug Administration approved bevacizumab for use in colon cancer 2004. The medicine was developed by Genentech and is marketed, in the United States by Genentech and elsewhere by Roche (Genentech's parent company), under the brand name Avastin.
Background
More on [ Bevacizumab ]
Bevacizumab May Benefit Some Women with Ovarian Cancer Illustration of a targeted drug binding to a cancer cell's... http://t.co/37oUBjve
DaddyDave1946 (Dave John Sexton) Sun, 05 Feb 2012 02:41:54 -0000
Bevacizumab May Benefit Some Women with Ovarian Cancer Illustration of a targeted drug binding to a cancer cell's... http://t.co/37oUBjve
#GU12 prior meta-analysis of bevacizumab saw 33% increased risk of treatment related deaths in randomized controlled trials
rabiyatuma (Rabiya Tuma) Sat, 04 Feb 2012 18:07:32 -0000
#GU12 prior meta-analysis of bevacizumab saw 33% increased risk of treatment related deaths in randomized controlled trials
One take-home mess
Avastin.com - Official pharmaceutical website with information for patients and health professionals.
Meta Description: [ Avastin has been approved by the FDA in combination with a specific type of chemotherapy (intravenous 5-fluorouracil [5-FU]-based chemotherapy) for first-line or second-line treatment of people diagnosed with metastatic colorectal cancer. ]
MedlinePlus: Bevacizumab (Systemic) - Data provided by NLM, the National Institutes of Health (NIH), government agencies and health-related organizations. Provides information on usage, precautions, side effects and brand names when available.
Meta Description: [ Bevacizumab(Systemic) ]
